The effects of exposures to mycotoxins on immunity in children: A systematic review.


Journal

Current problems in pediatric and adolescent health care
ISSN: 1538-3199
Titre abrégé: Curr Probl Pediatr Adolesc Health Care
Pays: United States
ID NLM: 101134613

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 28 5 2019
medline: 21 5 2020
entrez: 26 5 2019
Statut: ppublish

Résumé

The majority of childhood deaths occur in low-income countries, with vaccine-preventable infections contributing greatly. Of the many possible environmental factors that could hamper a child's immune response, mycotoxins rank among the least studied in spite of the high exposure in vulnerable populations. Aflatoxin crosses the placenta, is secreted in breast milk and is consumed widely in weaning diets by children with developing organ systems. This review describes the effects of mycotoxin exposure on immunity in children that may contribute to sub-optimal vaccine effectiveness. We searched electronic databases and references of identified articles for relevant studies on the effects of mycotoxins on the immune system in children. Geographical location, publication year, study design, sample selection, sample size, mean age, route of exposure were extracted on a standard template. Quality was assessed using Joanna Briggs Institute tool for appraisal of systematic reviews for prevalence studies. Our analyses and reporting were conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Out of 806 articles screened, 5 observational studies met criteria for inclusion for review. The definition of exposures to mycotoxins and outcomes varied across the studies. Exposure to mycotoxins was positively associated with low birth weight and concentration of antibodies to asexual malaria parasites and hepatitis B surface antigen, and negatively associated with death and sIgA, antibodies to pneumococcal antigen 23. Despite the far-reaching clinical and public health effects of mycotoxin exposure among children, studies on the effects of mycotoxin exposure on immunity in children were few, small and mostly of low quality. There is an urgent need for carefully designed prospective studies in this neglected field to inform policy interventions for child health in settings where exposure to mycotoxins is high.

Identifiants

pubmed: 31126742
pii: S1538-5442(19)30038-0
doi: 10.1016/j.cppeds.2019.04.004
pmc: PMC7116664
mid: EMS113475
pii:
doi:

Substances chimiques

Antibodies 0
Antigens 0
Mycotoxins 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-116

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203077
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):426-30
pubmed: 1440826
Environ Int. 2013 Feb;52:51-65
pubmed: 23291098
Avian Pathol. 1998;27(6):570-7
pubmed: 18484045
JAMA. 2012 Jan 25;307(4):391-7
pubmed: 22274686
PLoS Med. 2006 Aug;3(8):e311
pubmed: 16942395
Lancet. 2003 Jul 5;362(9377):65-71
pubmed: 12853204
MMWR Morb Mortal Wkly Rep. 1999 Apr 2;48(12):241-3
pubmed: 10220250
Ann Trop Paediatr. 1995 Sep;15(3):209-16
pubmed: 8534039
Lancet. 2005 Mar 12-18;365(9463):977-88
pubmed: 15767001
Environ Health Perspect. 2017 Jul 26;125(7):077018
pubmed: 28749778
Lancet. 2008 Feb 2;371(9610):417-40
pubmed: 18206226
JAMA Pediatr. 2016 Mar;170(3):267-87
pubmed: 26810619
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2009 Jan;26(1):108-18
pubmed: 19680878
Vaccine. 2011 Nov 8;29(48):8835-7
pubmed: 21971446
J Anim Sci. 2002 May;80(5):1250-7
pubmed: 12019612
Ann Trop Paediatr. 2004 Jun;24(2):145-51
pubmed: 15186543
J Toxicol Environ Health. 1997 Aug 29;51(6):623-8
pubmed: 9242232
Environ Health Perspect. 2003 Feb;111(2):217-20
pubmed: 12573908
Int J Mol Sci. 2009 Dec 21;10(12):5471-84
pubmed: 20054481
J Immunotoxicol. 2017 Dec;14(1):188-195
pubmed: 28805477

Auteurs

David Githang'a (D)

Department of Microbiology, College of Health Sciences, University of Nairobi, P.O. Box 19601-00202, Nairobi, Kenya. Electronic address: davidgithanga@gmail.com.

Omu Anzala (O)

KAVI-ICR, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya.

Charity Mutegi (C)

International Institute of Tropical Agriculture, P.O. Box 8019-00100, Nairobi, Kenya.

Ambrose Agweyu (A)

KEMRI-Wellcome Trust Research Programme, P.O. Box 43640 - 00100, Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH